Can a free-to-choose medicine pathway improve patient treatment?

The process of obtaining FDA approval for a new drug costs an estimated $1.8 billion and can take up to 15 years. What’s more, only a small percentage of drugs that undergo human clinical trials are approved.  To address this, Bartley J Madden, Research Fellow at the Madden Center for Value Creation at Florida Atlantic University, USA, has developed a free to choose medicine (FTCM) model that is currently being considered by US Congress.Read more in Research outreach Read the original research: econjwatch.org/science-on-fda-liberalization